1. Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches
   Ksenia Mitusova et al, 2022, Journal of Nanobiotechnology CrossRef
2. Mesenchymal stem cell-derived conditioned medium and Methysergide give rise to crosstalk inhibition of 5-HT2A and 5-HT7 receptors in neuroblastoma cells
   Hasan Salkin et al, 2023, Brain Research CrossRef
3. Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting
   Antonietta Rosella Farina et al, 2021, World Journal of Stem Cells CrossRef
4. The Potential of Mesenchymal Stromal Cells in Neuroblastoma Therapy for Delivery of Anti-Cancer Agents and Hematopoietic Recovery
   Caroline Hochheuser et al, 2021, Journal of Personalized Medicine CrossRef
5. Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters
   Mariela Montaño-Samaniego et al, 2020, Frontiers in Oncology CrossRef
6. RETRACTED: Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges
   Ehsan Razeghian et al, 2021, Frontiers in Immunology CrossRef
7. Challenges and Opportunities of Gene Therapy in Cancer
   Milky Mittal et al, 2024, OBM Genetics CrossRef
8. RETRACTED: Mesenchymal Stem/Stromal Cells as a Vehicle for Cytokine Delivery: An Emerging Approach for Tumor Immunotherapy
   Ehsan Razeghian et al, 2021, Frontiers in Medicine CrossRef